Anika Therapeutics, Inc.: accounts_receivable
| Value | {"amount": 16025212, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2015-03-31) |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:47.738007+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7bcf366e-87b3-41ea-9dcd-46c3936c4c2e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-15-002462Retrieved: 2026-08-19T09:02:47.738007+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/accounts-receivable/2015-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7bcf366e-87b3-41ea-9dcd-46c3936c4c2e
History
- no predecessors — first report